Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
about
Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.
P2860
Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Ketorolac prevents recurrent w ...... to spinal morphine in the rat.
@en
Ketorolac prevents recurrent w ...... to spinal morphine in the rat.
@nl
type
label
Ketorolac prevents recurrent w ...... to spinal morphine in the rat.
@en
Ketorolac prevents recurrent w ...... to spinal morphine in the rat.
@nl
prefLabel
Ketorolac prevents recurrent w ...... to spinal morphine in the rat.
@en
Ketorolac prevents recurrent w ...... to spinal morphine in the rat.
@nl
P2093
P2860
P1476
Ketorolac prevents recurrent w ...... to spinal morphine in the rat.
@en
P2093
Ivan Karamian
Jiahui Zhang
Stuart A Dunbar
P2860
P356
10.1016/J.EJPAIN.2005.12.007
P577
2006-01-30T00:00:00Z